Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells

Han Chieh Ko, Yea Hwey Wang, Kuo Tong Liou, Chi Ming Chen, Chih Hsiang Chen, Wen Yen Wang, Shiou Chang, Yu Chang Hou, Kuo Tung Chen, Chieh Fu Chen, Yuh Chiang Shen

Research output: Contribution to journalArticle

86 Citations (Scopus)

Abstract

Evodia rutaecarpa is commonly used as an anti-inflammatory drug in traditional Chinese medicine. We previously identified four bioactive compounds (dehydroevodiamine (I), evodiamine (II), rutaecarpine (III), and synephrine (IV)) from the ethanol extract of E. rutaecarpa, but their effects and mechanism(s) of action remain unclear. To study the anti-inflammatory potential and the possible underlying mechanism(s), their effects on phorbol-12-myristate-13-acetate (PMA)- and N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced reactive oxygen species production in neutrophils was studied, as well as lipopolysaccharide (LPS)-induced nitric oxide (NO) production and inducible NO synthetase (iNOS) expression in microglial cells. The ethanol extract of E. rutaecarpa displayed potent antioxidative effects against both PMA- and fMLP-induced reactive oxygen species production in neutrophils (with IC50 values of around 2.7-3.3 μg/ml). Although less potent than the ethanol extract of E. rutaecarpa, compounds I-IV all concentration-dependently inhibited PMA- and fMLP-induced reactive oxygen species production, with compound IV consistently being the most potent agent among these active components. The antioxidative effects of the ethanol extract of E. rutaecarpa and these compounds were partially due to inhibition (10%-33%) of NADPH oxidase activity, a predominant reactive oxygen species-producing enzyme in neutrophils, and to a minor extent to their direct radical-scavenging properties. The ethanol extract of E. rutaecarpa also inhibited LPS-induced NO production (with an IC50 of around 0.8 μg/ml) and iNOS upregulation in microglial cells that was partially mimicked by compounds I, II, and III, but not compound IV. Our results suggest that the ethanol extract of E. rutaecarpa and its four bioactive components all exhibited anti-inflammatory activities which could be partially explained by their different potentials for inhibiting NADPH oxidase-dependent reactive oxygen species and/or iNOS-dependent NO production in activated inflammatory cells.

Original languageEnglish
Pages (from-to)211-217
Number of pages7
JournalEuropean Journal of Pharmacology
Volume555
Issue number2-3
DOIs
Publication statusPublished - Jan 26 2007

Fingerprint

Evodia
Neutrophils
Anti-Inflammatory Agents
Ethanol
Reactive Oxygen Species
methionyl-leucyl-phenylalanine
dehydroevodiamine
Acetates
NADPH Oxidase
Nitric Oxide Synthase
Inhibitory Concentration 50
Lipopolysaccharides
Nitric Oxide
Synephrine
N-Formylmethionine Leucyl-Phenylalanine
Chinese Traditional Medicine
Ligases
Up-Regulation

Keywords

  • Dehydroevodiamine
  • Evodia rutaecarpa
  • Evodiamine
  • Inducible NO synthetase (iNOS)
  • Inflammation
  • Microglial cell
  • Neutrophil
  • Nitric oxide (NO)
  • Reactive oxygen species

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells. / Ko, Han Chieh; Wang, Yea Hwey; Liou, Kuo Tong; Chen, Chi Ming; Chen, Chih Hsiang; Wang, Wen Yen; Chang, Shiou; Hou, Yu Chang; Chen, Kuo Tung; Chen, Chieh Fu; Shen, Yuh Chiang.

In: European Journal of Pharmacology, Vol. 555, No. 2-3, 26.01.2007, p. 211-217.

Research output: Contribution to journalArticle

Ko, HC, Wang, YH, Liou, KT, Chen, CM, Chen, CH, Wang, WY, Chang, S, Hou, YC, Chen, KT, Chen, CF & Shen, YC 2007, 'Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells', European Journal of Pharmacology, vol. 555, no. 2-3, pp. 211-217. https://doi.org/10.1016/j.ejphar.2006.10.002
Ko, Han Chieh ; Wang, Yea Hwey ; Liou, Kuo Tong ; Chen, Chi Ming ; Chen, Chih Hsiang ; Wang, Wen Yen ; Chang, Shiou ; Hou, Yu Chang ; Chen, Kuo Tung ; Chen, Chieh Fu ; Shen, Yuh Chiang. / Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells. In: European Journal of Pharmacology. 2007 ; Vol. 555, No. 2-3. pp. 211-217.
@article{2ad4dab9dec0417084b9ed943b6a999f,
title = "Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells",
abstract = "Evodia rutaecarpa is commonly used as an anti-inflammatory drug in traditional Chinese medicine. We previously identified four bioactive compounds (dehydroevodiamine (I), evodiamine (II), rutaecarpine (III), and synephrine (IV)) from the ethanol extract of E. rutaecarpa, but their effects and mechanism(s) of action remain unclear. To study the anti-inflammatory potential and the possible underlying mechanism(s), their effects on phorbol-12-myristate-13-acetate (PMA)- and N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced reactive oxygen species production in neutrophils was studied, as well as lipopolysaccharide (LPS)-induced nitric oxide (NO) production and inducible NO synthetase (iNOS) expression in microglial cells. The ethanol extract of E. rutaecarpa displayed potent antioxidative effects against both PMA- and fMLP-induced reactive oxygen species production in neutrophils (with IC50 values of around 2.7-3.3 μg/ml). Although less potent than the ethanol extract of E. rutaecarpa, compounds I-IV all concentration-dependently inhibited PMA- and fMLP-induced reactive oxygen species production, with compound IV consistently being the most potent agent among these active components. The antioxidative effects of the ethanol extract of E. rutaecarpa and these compounds were partially due to inhibition (10{\%}-33{\%}) of NADPH oxidase activity, a predominant reactive oxygen species-producing enzyme in neutrophils, and to a minor extent to their direct radical-scavenging properties. The ethanol extract of E. rutaecarpa also inhibited LPS-induced NO production (with an IC50 of around 0.8 μg/ml) and iNOS upregulation in microglial cells that was partially mimicked by compounds I, II, and III, but not compound IV. Our results suggest that the ethanol extract of E. rutaecarpa and its four bioactive components all exhibited anti-inflammatory activities which could be partially explained by their different potentials for inhibiting NADPH oxidase-dependent reactive oxygen species and/or iNOS-dependent NO production in activated inflammatory cells.",
keywords = "Dehydroevodiamine, Evodia rutaecarpa, Evodiamine, Inducible NO synthetase (iNOS), Inflammation, Microglial cell, Neutrophil, Nitric oxide (NO), Reactive oxygen species",
author = "Ko, {Han Chieh} and Wang, {Yea Hwey} and Liou, {Kuo Tong} and Chen, {Chi Ming} and Chen, {Chih Hsiang} and Wang, {Wen Yen} and Shiou Chang and Hou, {Yu Chang} and Chen, {Kuo Tung} and Chen, {Chieh Fu} and Shen, {Yuh Chiang}",
year = "2007",
month = "1",
day = "26",
doi = "10.1016/j.ejphar.2006.10.002",
language = "English",
volume = "555",
pages = "211--217",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells

AU - Ko, Han Chieh

AU - Wang, Yea Hwey

AU - Liou, Kuo Tong

AU - Chen, Chi Ming

AU - Chen, Chih Hsiang

AU - Wang, Wen Yen

AU - Chang, Shiou

AU - Hou, Yu Chang

AU - Chen, Kuo Tung

AU - Chen, Chieh Fu

AU - Shen, Yuh Chiang

PY - 2007/1/26

Y1 - 2007/1/26

N2 - Evodia rutaecarpa is commonly used as an anti-inflammatory drug in traditional Chinese medicine. We previously identified four bioactive compounds (dehydroevodiamine (I), evodiamine (II), rutaecarpine (III), and synephrine (IV)) from the ethanol extract of E. rutaecarpa, but their effects and mechanism(s) of action remain unclear. To study the anti-inflammatory potential and the possible underlying mechanism(s), their effects on phorbol-12-myristate-13-acetate (PMA)- and N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced reactive oxygen species production in neutrophils was studied, as well as lipopolysaccharide (LPS)-induced nitric oxide (NO) production and inducible NO synthetase (iNOS) expression in microglial cells. The ethanol extract of E. rutaecarpa displayed potent antioxidative effects against both PMA- and fMLP-induced reactive oxygen species production in neutrophils (with IC50 values of around 2.7-3.3 μg/ml). Although less potent than the ethanol extract of E. rutaecarpa, compounds I-IV all concentration-dependently inhibited PMA- and fMLP-induced reactive oxygen species production, with compound IV consistently being the most potent agent among these active components. The antioxidative effects of the ethanol extract of E. rutaecarpa and these compounds were partially due to inhibition (10%-33%) of NADPH oxidase activity, a predominant reactive oxygen species-producing enzyme in neutrophils, and to a minor extent to their direct radical-scavenging properties. The ethanol extract of E. rutaecarpa also inhibited LPS-induced NO production (with an IC50 of around 0.8 μg/ml) and iNOS upregulation in microglial cells that was partially mimicked by compounds I, II, and III, but not compound IV. Our results suggest that the ethanol extract of E. rutaecarpa and its four bioactive components all exhibited anti-inflammatory activities which could be partially explained by their different potentials for inhibiting NADPH oxidase-dependent reactive oxygen species and/or iNOS-dependent NO production in activated inflammatory cells.

AB - Evodia rutaecarpa is commonly used as an anti-inflammatory drug in traditional Chinese medicine. We previously identified four bioactive compounds (dehydroevodiamine (I), evodiamine (II), rutaecarpine (III), and synephrine (IV)) from the ethanol extract of E. rutaecarpa, but their effects and mechanism(s) of action remain unclear. To study the anti-inflammatory potential and the possible underlying mechanism(s), their effects on phorbol-12-myristate-13-acetate (PMA)- and N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced reactive oxygen species production in neutrophils was studied, as well as lipopolysaccharide (LPS)-induced nitric oxide (NO) production and inducible NO synthetase (iNOS) expression in microglial cells. The ethanol extract of E. rutaecarpa displayed potent antioxidative effects against both PMA- and fMLP-induced reactive oxygen species production in neutrophils (with IC50 values of around 2.7-3.3 μg/ml). Although less potent than the ethanol extract of E. rutaecarpa, compounds I-IV all concentration-dependently inhibited PMA- and fMLP-induced reactive oxygen species production, with compound IV consistently being the most potent agent among these active components. The antioxidative effects of the ethanol extract of E. rutaecarpa and these compounds were partially due to inhibition (10%-33%) of NADPH oxidase activity, a predominant reactive oxygen species-producing enzyme in neutrophils, and to a minor extent to their direct radical-scavenging properties. The ethanol extract of E. rutaecarpa also inhibited LPS-induced NO production (with an IC50 of around 0.8 μg/ml) and iNOS upregulation in microglial cells that was partially mimicked by compounds I, II, and III, but not compound IV. Our results suggest that the ethanol extract of E. rutaecarpa and its four bioactive components all exhibited anti-inflammatory activities which could be partially explained by their different potentials for inhibiting NADPH oxidase-dependent reactive oxygen species and/or iNOS-dependent NO production in activated inflammatory cells.

KW - Dehydroevodiamine

KW - Evodia rutaecarpa

KW - Evodiamine

KW - Inducible NO synthetase (iNOS)

KW - Inflammation

KW - Microglial cell

KW - Neutrophil

KW - Nitric oxide (NO)

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=33846031082&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846031082&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2006.10.002

DO - 10.1016/j.ejphar.2006.10.002

M3 - Article

VL - 555

SP - 211

EP - 217

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -